• About
  • Interesting shortcuts
  • Programmes and Partnerships
    • Search
    • European Partnerships
    • EU-Programme-Call
  • Projects
    • Projects
  • Resources
    • Resources
  • www.decubber.com
    • Login
  • Programmes and Partnerships
  • EU-Programme-Call
  • Horizon 2020
  • H2020-EU.3. SOCIETAL CHALLENGES
  • H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being

H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being

Mapped projects (1221)
  • H2020-EU.3.1.0. Cross-cutting call topics
    (386)
    • H2020-Adhoc-2014-20
      (10)
    • H2020-HCO-2014
      (4)
    • H2020-IBA-SC1-BIOMEDICAL-2017
      (1)
    • H2020-IBA-SC1-CORONAVIRUS-2020-4
      (1)
    • H2020-IBA-SC1-eHealth-2017
      (1)
    • H2020-IBA-SC1-Presidency-2020
      (1)
    • H2020-JTI-IMI2-2015-08-single-stage
      (4)
    • H2020-JTI-IMI2-2020-20-two-stage
      (6)
    • H2020-JTI-IMI2-2020-22-single-stage
      (4)
    • H2020-JTI-IMI2-2020-23-two-stage
      (6)
    • H2020-PHC-2014-single-stage
      (19)
    • H2020-SC1-2020-Single-Stage-RTD
      (46)
    • H2020-SC1-2020-Two-Stage-RTD
      (16)
    • H2020-SC1-DTH-2020-1
      (16)
    • H2020-SC1-FA-DTS-2020-1
      (4)
    • H2020-SC1-PHE-CORONAVIRUS-2020-2-CNECT
      (13)
    • H2020-SC1-PHE-CORONAVIRUS-2020-2-RTD
      (19)
    • H2020-SMEINST-1-2014
      (77)
    • H2020-SMEINST-2-2014
      (19)
    • H2020-SMEINST-2-2015
      (12)
    • H2020-SMEINST-2-2016-2017
      (107)
  • H2020-EU.3.1.1. Understanding health, wellbeing and disease
    (86)
    • H2020-HCO-2014
      (1)
    • H2020-PHC-2014-two-stage
      (14)
    • H2020-PHC-2015-two-stage
      (15)
    • H2020-SC1-2016-RTD
      (8)
    • H2020-SC1-2017-Single-Stage-RTD
      (2)
    • H2020-SC1-2017-Two-Stage-RTD
      (7)
    • H2020-SC1-2018-Single-Stage-RTD
      (13)
    • H2020-SC1-2019-Single-Stage-RTD
      (6)
    • H2020-SC1-2019-Two-Stage-RTD
      (20)
  • H2020-EU.3.1.2. Preventing disease
    (53)
    • H2020-PHC-2014-single-stage
      (3)
    • H2020-PHC-2014-two-stage
      (5)
    • H2020-PHC-2015-single-stage_RTD
      (2)
    • H2020-PHC-2015-two-stage
      (3)
    • H2020-SC1-2016-RTD
      (7)
    • H2020-SC1-2017-Two-Stage-RTD
      (5)
    • H2020-SC1-2018-Single-Stage-RTD
      (3)
    • H2020-SC1-2019-Single-Stage-RTD
      (15)
    • H2020-SC1-2019-Two-Stage-RTD
      (9)
    • H2020-SGA-SC1-CEPI-2019
      (1)
  • H2020-EU.3.1.3. Treating and managing disease
    (527)
    • H2020-EU.3.1.3.0. Cross-cutting call topics
      (518)
    • H2020-EU.3.1.3.2. Transferring knowledge to clinical practice and scalable innovation actions
      (9)
  • H2020-EU.3.1.4. Active ageing and self-management of health
    (164)
    • H2020-EU.3.1.4.0. Cross-cutting call topics
      (142)
    • H2020-EU.3.1.4.1. Active ageing, independent and assisted living
      (20)
    • H2020-EU.3.1.4.2. Individual awareness and empowerment for self-management of health
      (12)
  • H2020-EU.3.1.5. Methods and data
    (76)
    • H2020-EU.3.1.5.0. Cross-cutting call topics
      (46)
    • H2020-EU.3.1.5.1. Improving halth information and better use of health data
      (26)
    • H2020-EU.3.1.5.2. Improving scientific tools and methods to support policy making and regulatory needs
      (2)
    • H2020-EU.3.1.5.3. Using in-silico medicine for improving disease management and prediction
      (3)
  • H2020-EU.3.1.6. Health care provision and integrated care
    (155)
    • H2020-EU.3.1.6.0. Cross-cutting call topics
      (151)
    • H2020-EU.3.1.6.2. Optimising the efficiency and effectiveness of healthcare provision and reducing inequalities by evidence based decision making and dissemination of best practice, and innovative technologies and approaches
      (4)
  • H2020-EU.3.1.7. Innovative Medicines Initiative 2 (IMI2)
    (108)
    • H2020-EU.3.1.7.0. Cross-cutting call topics
      (105)
    • H2020-EU.3.1.7.1. Antimicrobial resistance
    • H2020-EU.3.1.7.12. Vaccine
      (1)
    • H2020-EU.3.1.7.13. Other
      (5)
    • H2020-EU.3.1.7.4. Diabetes
    • H2020-EU.3.1.7.5. Neurodegenerative diseases
    • H2020-EU.3.1.7.6. Psychiatric diseases
    • H2020-EU.3.1.7.8. Immune-mediated diseases
Powered by Chris Decubber BV